BMR now trades at a 17% discount to consensus NAV, and while earnings noise such as the lease terminations and the potentially dilutive $300M asset sale in DC are near-term concerns, in the context of a potential takeout, the focus will likely shift to less transitory phenomena and toward the broader context of a highly-differentiated biotech lab platform with a real estate portfolio that is concentrated in numerous best markets in the United States.
Advertisement
An earnings surprise is the calculated difference between a firm’s expected earnings numbers provided by Wall Street analysts and the actual reported numbers. Since firms often use different terminology for their Buy/Sell recommendations, Zacks offers a consensus analyst rating on each stock based on a sliding 1 to 5 scale, where 1 is a Strong Buy a 5 a Strong Sell.
Brandywine Realty Trust (NYSE:BDN) last issued its earnings results on Wednesday, July 22nd. The total value of transaction was $29,495.
HR has been the subject of a number of other reports.
Biomed Realty Trust (NYSE:BMR) had its price objective decreased by Mizuho from $23.00 to $21.00 in a research note published on Monday, AnalystRatingsNetwork.com reports. Wood & Company lowered shares of Brandywine Realty Trust from a “buy” rating to a “hold” rating in a report on Friday, June 26th.
Inc(ADR) (NASDAQ:JD) China’s largest online direct sales company, recently declared that its Board of Directors has authorized a share repurchase program under which the Company may repurchase up to US$1.0 billion worth of its American depositary shares (“ADSs”) over the next 24 months. Finally, Stifel Nicolaus downgraded shares of Brandywine Realty Trust from a “buy” rating to a “hold” rating in a research report on Thursday, June 25th. 2 stock experts have also rated a buy. The company presently has an average rating of “Hold” and a consensus target price of $106.36. Last month, John Bonanno, a the EVP, Development & Investments of BMR sold 4,800 shares for a total of $100,848. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink.
The stock had changed since market close yesterday.
In terms of price targets, sell-side brokerage firms are projecting that the stock will reach the range of $28-32. The disclosure for this purchase can be found here. Around 2.10 million shares have been traded, versus an-average trading volume of 5.74 million shares. Healthcare Realty Trust has a 52-week low of $22.01 and a 52-week high of $31.20.
Advertisement
According to Zacks, “Digital Realty Trust owns, acquires, repositions and manages technology-related real estate”. The Company’s operations are conducted through, directly or indirectly, Agree Limited Partnership (Operating Partnership), of which the Company is the sole general partner, and in which it 96.59% interest as of December 31, 2011.
